These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 16152701)

  • 1. Lenacapavir.
    Beninger P
    Clin Ther; 2024 Feb; 46(2):183-184. PubMed ID: 38326158
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood immune cells from people with HIV on antiviral regimens that contain tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) have differential metabolic signatures.
    Ritou E; Satta S; Petcherski A; Daskou M; Sharma M; Vasilopoulos H; Murakami E; Shirihai OS; Kelesidis T
    Metabolism; 2023 Apr; 141():155395. PubMed ID: 36842771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviruses conference: overview, information available.
    James JS
    AIDS Treat News; 2000 Feb; (No 336):2-5. PubMed ID: 11367205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can it get even better than this? You don't need to trade in for a newer model-you can live longer and better...while controlling HIV.
    Smigelski C
    Posit Aware; 2006; Spec No():19-21. PubMed ID: 17233082
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
    Côté HC; Magil AB; Harris M; Scarth BJ; Gadawski I; Wang N; Yu E; Yip B; Zalunardo N; Werb R; Hogg R; Harrigan PR; Montaner JS
    Antivir Ther; 2006; 11(1):79-86. PubMed ID: 16518963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria, HIV infection and its treatment: where do we go from here?
    Cossarizza A; Reiss P
    Antivir Ther; 2005; 10 Suppl 2():M1-2. PubMed ID: 16152701
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 8. Current HIV therapeutics: mechanistic and chemical determinants of toxicity.
    Chiao SK; Romero DL; Johnson DE
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):53-60. PubMed ID: 19152213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria.
    Moyle G
    Antivir Ther; 2005; 10 Suppl 2():M47-52. PubMed ID: 16152705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
    Côté HC
    Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.